ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

How early screening for type 1 diabetes and follow up monitoring can help you plan for the future

(BPT) - Sponsored by Sanofi

Life often brings surprises, and many can be welcome. However, sometimes being caught off guard can be scary or overwhelming. This is especially true when it comes to your health, for example receiving an unexpected diagnosis like that of type 1 diabetes.

People often find out they have type 1 diabetes when they are in a later stage (stage 3) of the disease, which is when clinical symptoms begin to occur. In stage three, the body is no longer able to make enough or any insulin which causes blood sugar levels to rise much higher than the normal range. What happens next is lifelong dependence on insulin injections to maintain target blood sugar levels - and it may carry a heavy burden for individuals and their families alike.

Karim Jones and her family know this feeling all too well. Unknowingly, Jones' daughter was experiencing tell-tale symptoms of type 1 diabetes, including extreme thirst, unexplained weight loss, and fatigue. When they went to the doctor, Jones remembered a previous conversation she had with a friend and asked the doctor to test her daughter for type 1 diabetes. It turned out her daughter not only had type 1 diabetes, but she was also in diabetic ketoacidosis (DKA), a life-threatening complication of type 1 diabetes.

Jones immediately received a deluge of information about managing her daughter's blood sugar levels, the impact of diet, insulin dosing, and more, which made her feel overwhelmed and uncertain. When the stakes are as high as supporting a child's health, more time to learn how to manage the disease can be extremely valuable. Early detection of type 1 diabetes is possible through screening and this advanced information can provide time to prepare for the future - but early screening for type 1 diabetes is relatively uncommon prior to diagnosis due largely to a lack of awareness. The1Pledge.com has more information on why early screening can be important.

'Knowing in advance, even by just one month, would have made an important difference for our entire family and given us the time to prepare in a way that wasn't so rushed,' Jones shares. 'Type 1 diabetes management requires countless extra decisions each day that I'm responsible for as a caregiver. It's on me to manage my daughter's health, and the mental load that goes along with that responsibility is one of the hardest parts.'

Indeed, advanced notice through a blood test that can detect type 1 diabetes-related autoantibodies early can help families in a multitude of ways, including but not limited to:

  • Building a multidisciplinary care team of doctors, nurses, nutritionists, and other supportive healthcare providers to meet with (typically every 3-6 months).
  • Learning more about the disease from that care team to better recognize symptoms when they do arise (stage 3) and potentially reducing the risk of going through DKA by up to 50%.
  • Developing the skills needed to manage the disease, in the face of up to 10 finger pricks per day to measure blood sugar and an estimated 1,460 insulin injections each year.

'My husband and I agreed that we never wanted to be caught off guard like that again, so after my daughter was diagnosed, our whole family got screened, including our other three children,' Jones notes. 'As a parent, you would do anything for your kids, and when I learned screening was an option after my daughter's diagnosis, I wasn't going to miss out on an opportunity to know if my family was at risk. Before we got the family screened, I felt like I was living in fear, worried that if my child was thirsty, it might be a red flag; now that we've gotten the kids screened, I feel better informed.'

Jones continued: 'As a mother who has lived through an unexpected diagnosis, I believe everyone should get screened. About 90% of people diagnosed with type 1 diabetes do not have a family history of the disease, which was the case for my daughter. If it's fear of knowing that's stopping you from getting screened, hear me when I say that you don't want to get to a point where your child is experiencing DKA - that is much, much scarier. Knowing in advance may make a difference for your family.'

Talk to your doctor about screening for type 1 diabetes.

Sanofi does not provide medical advice, diagnosis, or treatment - information is provided for educational purposes only. Your doctor is the best source of health information. Talk to your doctor if you have any questions about your health or treatment.

Karim Jones is a paid spokesperson for Sanofi.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.14
-5.55 (-2.49%)
AAPL  266.25
-2.31 (-0.86%)
AMD  206.02
-17.53 (-7.84%)
BAC  51.00
-1.02 (-1.96%)
GOOG  289.98
-3.01 (-1.03%)
META  589.15
-1.17 (-0.20%)
MSFT  478.43
-8.69 (-1.78%)
NVDA  180.64
-5.88 (-3.15%)
ORCL  210.69
-14.84 (-6.58%)
TSLA  395.23
-8.76 (-2.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.